These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term safety of ultrathin bioabsorbable-polymer sirolimus-eluting stents versus thin durable-polymer drug-eluting stents in acute coronary syndrome: A systematic review and meta-analysis. Li F; Wang S; Wang Y; Wei C; Wang Y; Liu X; Sun S; Zhao W; Guo P; Wu X Clin Cardiol; 2023 Dec; 46(12):1465-1473. PubMed ID: 37661458 [TBL] [Abstract][Full Text] [Related]
5. Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial. Zbinden R; Piccolo R; Heg D; Roffi M; Kurz DJ; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Franzone A; Eberli F; Jüni P; Windecker S; Pilgrim T J Am Heart Assoc; 2016 Mar; 5(3):e003255. PubMed ID: 26979080 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study. Dangas G; Baber U; Sharma S; Giustino G; Sartori S; Nicolas J; Goel R; Mehta S; Cohen D; Angiolillo DJ; Zhang Z; Camaj A; Cao D; Briguori C; Dudek D; Escaned J; Huber K; Collier T; Kornowski R; Kunadian V; Moliterno DJ; Ohman EM; Weisz G; Gil R; Krucoff MW; Kaul U; Oldroyd KG; Sardella G; Shlofmitz R; Witzenbichler B; Kastrati A; Han YL; Steg PG; Pocock S; Gibson CM; Mehran R EuroIntervention; 2022 Mar; 17(16):1330-1339. PubMed ID: 34881696 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent). Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236 [TBL] [Abstract][Full Text] [Related]
9. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]
10. Five-Year Outcomes of Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Durable Polymer Drug-Eluting Stents: a Meta-Analysis of Randomized Controlled Trials. Lou Y; Yu Y; Xi Z; Gao Y; Liu W; Nie X Cardiovasc Drugs Ther; 2019 Oct; 33(5):557-566. PubMed ID: 31773343 [TBL] [Abstract][Full Text] [Related]
11. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization. Yamaji K; Zanchin T; Zanchin C; Stortecky S; Koskinas KC; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Valgimigli M; Billinger M; Pilgrim T; Heg D; Windecker S; Räber L Circ Cardiovasc Interv; 2018 Sep; 11(9):e006741. PubMed ID: 30354590 [TBL] [Abstract][Full Text] [Related]
12. Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents. Iglesias JF; Heg D; Roffi M; Tüller D; Lanz J; Rigamonti F; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Valgimigli M; Jüni P; Windecker S; Pilgrim T J Am Heart Assoc; 2019 Nov; 8(22):e013607. PubMed ID: 31696762 [TBL] [Abstract][Full Text] [Related]
13. Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR. Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Heart Vessels; 2019 Feb; 34(2):237-250. PubMed ID: 30167772 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372 [TBL] [Abstract][Full Text] [Related]
19. One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents. Azzalini L; Baber U; Johal GS; Farhan S; Barman N; Kapur V; Hasan C; Vijay P; Jhaveri V; Mehran R; Kini AS; Sharma SK Catheter Cardiovasc Interv; 2021 Jun; 97(7):1341-1351. PubMed ID: 32478459 [TBL] [Abstract][Full Text] [Related]
20. Durable polymer versus biodegradable polymer drug-eluting stents in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: a post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial. Hwang D; Lim HS; Park KW; Shin WY; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Cho YK; Hong SJ; Kim S; Jo SH; Kim YH; Kim W; Lee SY; Oh SK; Kim DB; Kim HS EuroIntervention; 2022 Dec; 18(11):e910-e919. PubMed ID: 36000257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]